STAT

Opinion: Assessing the value of new food allergy treatments must include quality of life

Breakthrough treatments in immunotherapy offer people with food allergies a choice beyond avoiding foods, a shot of epinephrine, and a trip to the emergency room.

Walk into any classroom in America today and you’ll likely find at least two children with a food allergy. More than 40% of such children have experienced a serious allergic reaction such as anaphylaxis, a severe, potentially life-threatening allergic reaction that can occur suddenly after exposure to something you’re allergic to, such as peanuts.

This epidemic doesn’t just affect children: 1 in 10 adults in the U.S. have at least one food allergy. More than are currently living with food allergies. That’s the combined population of New

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Wegovy And Ozempic Sales, Rising Pharma Layoffs, And More
Sales of the blockbuster Wegovy obesity treatment more than doubled in the first quarter as Novo Nordisk races to make more of the drug to meet surging demand.
STAT2 min readCrime & Violence
STAT+: Pharmalittle: We’re Reading About A Medicare Price-negotiation Ruling, Pharma’s Slipping Reputation, And More
A U.S. judge dealt a blow to two drugmakers challenging the authority for Medicare to negotiate the prices of prescription drugs.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.

Related Books & Audiobooks